Skip to content
Disclosery

Antipodean Advisors LLC

Follow

13F filer, CIK 1512566, New York, NY

Antipodean Advisors LLC reported $16,163,220 across 8 holdings for the quarter ended 2023-03-31, in a 13F-HR filed 2023-05-15.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000919574-23-003114

Period
2023-03-31
Reported value
$16.2M
Holdings
8
Top 10 weight
100%
New
2
Sold out
2

Largest buys vs the previous quarter

SecurityShares changeApprox. value
INVESTMENT MANAGERS SER TR Inew+75,000$3.19M
GDXadded+65,000$2.1M
COINnew+3,500$236K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
SEreduced-280,000-$24.2M
GLDexited-35,000-$5.94M
CVNAreduced-15,000-$147K
CDLXreduced-40,000-$136K
UPSTexited-10,000-$132K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2023

Share positions as resolved from 13F-HR 0000919574-23-003114, largest first. % of portfolio is the value over $16,163,220, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
SESEA LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: 350,000 shares; 2022Q1: 350,000 shares; 2022Q2: 350,000 shares; 2022Q3: 350,000 shares; 2022Q4: 350,000 shares; 2023Q1: 70,000 shares 70,000$6.06M37.48%-280,000Timeline
INVESTMENT MANAGERS SER TR IINVESTMENT MANAGERS SER TR IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not reported; 2022Q1: not reported; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: not reported; 2023Q1: 75,000 shares 75,000$3.19M19.74%new
ATARA BIOTHERAPEUTICS INC C…ATARA BIOTHERAPEUTICS INC COM NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: 1,000,000 shares; 2022Q1: 1,000,000 shares; 2022Q2: 1,000,000 shares; 2022Q3: 1,000,000 shares; 2022Q4: 1,000,000 shares; 2023Q1: 1,000,000 shares 1,000,000$2.9M17.94%0
GDXVANECK ETF TRUSTQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not reported; 2022Q1: not reported; 2022Q2: 60,000 shares; 2022Q3: 10,000 shares; 2022Q4: 10,000 shares; 2023Q1: 75,000 shares 75,000$2.43M15.01%+65,000Timeline
CAREMAX INCCAREMAX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: 600,000 shares; 2022Q1: 425,000 shares; 2022Q2: 425,000 shares; 2022Q3: 425,000 shares; 2022Q4: 425,000 shares; 2023Q1: 425,000 shares 425,000$1.13M7.02%0
COINCOINBASE GLOBAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not reported; 2022Q1: not reported; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: not reported; 2023Q1: 3,500 shares 3,500$236K1.46%newTimeline
CDLXCARDLYTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: 638,800 shares; 2022Q1: 638,800 shares; 2022Q2: 638,800 shares; 2022Q3: 540,400 shares; 2022Q4: 75,000 shares; 2023Q1: 35,000 shares 35,000$119K0.74%-40,000Timeline
CVNACARVANA COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: 405,000 shares; 2022Q1: 405,000 shares; 2022Q2: 405,000 shares; 2022Q3: 355,000 shares; 2022Q4: 25,000 shares; 2023Q1: 10,000 shares 10,000$97.9K0.61%-15,000Timeline

Sold out in Q1 2023

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
GLDSPDR GOLD TR35,000$5.94Mshares
UPSTUPSTART HLDGS INC10,000$132Kshares

How Q1 2023 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000919574-23-003114 base2023-05-15acceptance time not in the bulk data set